CAMP4 Therapeutics (CAMP)
4.14
+0.03 (0.73%)
Upcoming Events
Latest Headlines
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 21, 2026 4:05 PM - StreetInsider
CAMP4 Therapeutics reports seizure improvements in preclinical study
May 14, 2026 7:00 AM - StreetInsider
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
May 14, 2026 7:00 AM - Globe NewsWire
Calamp Corp. (CAMP) Misses Q1 EPS by 3c
May 8, 2026 5:54 PM - StreetInsider
CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026 4:05 PM - StreetInsider
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
April 28, 2026 8:00 AM - Globe NewsWire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 17, 2026 4:05 PM - StreetInsider
Rodman & Renshaw Starts CAMP4 Therapeutics Corp (CAMP) at Buy
April 14, 2026 6:31 AM - StreetInsider
Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Tardiff Daniel
April 3, 2026 4:48 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Maricich Yuri
April 3, 2026 4:47 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Gold Kelly
April 3, 2026 4:47 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Mandel-Brehm Josh
April 3, 2026 4:47 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: MacLean Michael F
April 3, 2026 4:45 PM - SEC Filing
Form 3 Camp4 Therapeutics Corp For: Apr 01 Filed by: MacLean Michael F
April 3, 2026 4:43 PM - SEC Filing
CAMP4 Therapeutics Corp (CAMP) PT Raised to $9 at Leerink Partners
April 2, 2026 6:19 AM - StreetInsider
CAMP4 appoints Michael MacLean to board of directors
March 24, 2026 7:01 AM - StreetInsider
CAMP4 Appoints Michael MacLean to its Board of Directors
March 24, 2026 7:00 AM - StreetInsider
Full Article List
